메뉴 건너뛰기




Volumn 415, Issue 1, 2011, Pages 163-167

Protein kinase CK2 modulates IL-6 expression in inflammatory breast cancer

Author keywords

CK2; CX 4945; IL 6; Inflammatory breast cancer

Indexed keywords

ANTINEOPLASTIC AGENT; BETA ACTIN; CASEIN KINASE II; CX 4945; INTERLEUKIN 6; SMALL INTERFERING RNA; STAT3 PROTEIN; UNCLASSIFIED DRUG;

EID: 80755188923     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.10.046     Document Type: Article
Times cited : (59)

References (26)
  • 2
    • 0034518232 scopus 로고    scopus 로고
    • RhoC GTPase overexpression modulates induction of angiogenic factors in breast cells
    • van Golen K.L., Wu Z.F., Qiao X.T., Bao L., Merajver S.D. RhoC GTPase overexpression modulates induction of angiogenic factors in breast cells. Neoplasia 2000, 2:418-425.
    • (2000) Neoplasia , vol.2 , pp. 418-425
    • van Golen, K.L.1    Wu, Z.F.2    Qiao, X.T.3    Bao, L.4    Merajver, S.D.5
  • 3
    • 77950690023 scopus 로고    scopus 로고
    • Interleukin-6 in bone metastasis and cancer progression
    • Ara T., Declerck Y.A. Interleukin-6 in bone metastasis and cancer progression. Eur. J. Cancer 2010, 46:1223-1231.
    • (2010) Eur. J. Cancer , vol.46 , pp. 1223-1231
    • Ara, T.1    Declerck, Y.A.2
  • 4
    • 0031969898 scopus 로고    scopus 로고
    • Serum levels of interleukin-6 as a prognostic factor in advanced non-small cell lung cancer
    • De Vita F., Orditura M., Auriemma A., Infusino S., Roscigno A., Catalano G. Serum levels of interleukin-6 as a prognostic factor in advanced non-small cell lung cancer. Oncol. Rep. 1998, 5:649-652.
    • (1998) Oncol. Rep. , vol.5 , pp. 649-652
    • De Vita, F.1    Orditura, M.2    Auriemma, A.3    Infusino, S.4    Roscigno, A.5    Catalano, G.6
  • 5
    • 0033036097 scopus 로고    scopus 로고
    • Serum interleukin-6 levels correlate to tumor progression and prognosis in metastatic breast carcinoma
    • Zhang G.J., Adachi I. Serum interleukin-6 levels correlate to tumor progression and prognosis in metastatic breast carcinoma. Anticancer Res. 1999, 19:1427-1432.
    • (1999) Anticancer Res. , vol.19 , pp. 1427-1432
    • Zhang, G.J.1    Adachi, I.2
  • 6
    • 77649239393 scopus 로고    scopus 로고
    • Serum interleukin-6 levels in colorectal cancer patients - a summary of published results
    • Knupfer H., Preiss R. Serum interleukin-6 levels in colorectal cancer patients - a summary of published results. Int. J. Colorectal Dis. 2010, 25:135-140.
    • (2010) Int. J. Colorectal Dis. , vol.25 , pp. 135-140
    • Knupfer, H.1    Preiss, R.2
  • 8
    • 0142250392 scopus 로고    scopus 로고
    • Targeted anti-interleukin-6 monoclonal antibody therapy for cancer: a review of the rationale and clinical evidence
    • Trikha M., Corringham R., Klein B., Rossi J.F. Targeted anti-interleukin-6 monoclonal antibody therapy for cancer: a review of the rationale and clinical evidence. Clin. Cancer Res. 2003, 9:4653-4665.
    • (2003) Clin. Cancer Res. , vol.9 , pp. 4653-4665
    • Trikha, M.1    Corringham, R.2    Klein, B.3    Rossi, J.F.4
  • 10
    • 1542719614 scopus 로고    scopus 로고
    • Hemoadsorption removes tumor necrosis factor, interleukin-6, interleukin-10, reduces nuclear factor-kappaB DNA binding, and improves short-term survival in lethal endotoxemia
    • Kellum J.A., Song M., Venkataraman R. Hemoadsorption removes tumor necrosis factor, interleukin-6, interleukin-10, reduces nuclear factor-kappaB DNA binding, and improves short-term survival in lethal endotoxemia. Crit. Care Med. 2004, 32:801-805.
    • (2004) Crit. Care Med. , vol.32 , pp. 801-805
    • Kellum, J.A.1    Song, M.2    Venkataraman, R.3
  • 11
    • 33644759333 scopus 로고    scopus 로고
    • Targeting effective blood pressure control with angiotensin receptor blockers
    • Asmar R. Targeting effective blood pressure control with angiotensin receptor blockers. Int. J. Clin. Pract. 2006, 60:315-320.
    • (2006) Int. J. Clin. Pract. , vol.60 , pp. 315-320
    • Asmar, R.1
  • 12
    • 67749084409 scopus 로고    scopus 로고
    • The clinical efficacy of tocilizumab in rheumatoid arthritis
    • Mircic M., Kavanaugh A. The clinical efficacy of tocilizumab in rheumatoid arthritis. Drugs Today (Barc) 2009, 45:189-197.
    • (2009) Drugs Today (Barc) , vol.45 , pp. 189-197
    • Mircic, M.1    Kavanaugh, A.2
  • 13
    • 53249090648 scopus 로고    scopus 로고
    • Protein kinase CK2 in human diseases
    • Guerra B., Issinger O.G. Protein kinase CK2 in human diseases. Curr. Med. Chem. 2008, 15:1870-1886.
    • (2008) Curr. Med. Chem. , vol.15 , pp. 1870-1886
    • Guerra, B.1    Issinger, O.G.2
  • 14
    • 75349084777 scopus 로고    scopus 로고
    • Addiction to protein kinase CK2: a common denominator of diverse cancer cells?
    • Ruzzene M., Pinna L.A. Addiction to protein kinase CK2: a common denominator of diverse cancer cells?. Biochim. Biophys. Acta 2010, 1804:499-504.
    • (2010) Biochim. Biophys. Acta , vol.1804 , pp. 499-504
    • Ruzzene, M.1    Pinna, L.A.2
  • 15
    • 34447345994 scopus 로고    scopus 로고
    • The role of protein kinase CK2 in intestinal epithelial cell inflammatory signaling
    • Parhar K., Morse J., Salh B. The role of protein kinase CK2 in intestinal epithelial cell inflammatory signaling. Int. J. Colorectal Dis. 2007, 22:601-609.
    • (2007) Int. J. Colorectal Dis. , vol.22 , pp. 601-609
    • Parhar, K.1    Morse, J.2    Salh, B.3
  • 16
    • 27744470520 scopus 로고    scopus 로고
    • Role for casein kinase 2 in the regulation of HIF-1 activity
    • Mottet D., Ruys S.P., Demazy C., Raes M., Michiels C. Role for casein kinase 2 in the regulation of HIF-1 activity. Int. J. Cancer 2005, 117:764-774.
    • (2005) Int. J. Cancer , vol.117 , pp. 764-774
    • Mottet, D.1    Ruys, S.P.2    Demazy, C.3    Raes, M.4    Michiels, C.5
  • 19
    • 26844578050 scopus 로고    scopus 로고
    • In vitro analysis of the invasive phenotype of SUM 149, an inflammatory breast cancer cell line
    • Hoffmeyer M.R., Wall K.M., Dharmawardhane S.F. In vitro analysis of the invasive phenotype of SUM 149, an inflammatory breast cancer cell line. Cancer Cell. Int. 2005, 5:11.
    • (2005) Cancer Cell. Int. , vol.5 , pp. 11
    • Hoffmeyer, M.R.1    Wall, K.M.2    Dharmawardhane, S.F.3
  • 20
    • 0031432550 scopus 로고    scopus 로고
    • IL-6-regulated transcription factors
    • Akira S. IL-6-regulated transcription factors. Int. J. Biochem. Cell Biol. 1997, 29:1401-1418.
    • (1997) Int. J. Biochem. Cell Biol. , vol.29 , pp. 1401-1418
    • Akira, S.1
  • 21
    • 77952687319 scopus 로고    scopus 로고
    • Novel targeted therapies in inflammatory breast cancer
    • Cristofanilli M. Novel targeted therapies in inflammatory breast cancer. Cancer 2011, 116:2837-2839.
    • (2011) Cancer , vol.116 , pp. 2837-2839
    • Cristofanilli, M.1
  • 22
    • 0029959753 scopus 로고    scopus 로고
    • Pyrrolidine dithiocarbamate inhibits the production of interleukin-6 interleukin-8 and granulocyte-macrophage colony-stimulating factor by human endothelial cells in response to inflammatory mediators: modulation of NF-kappa B and AP-1 transcription factors activity
    • Munoz C., Pascual-Salcedo D., Castellanos M.C., Alfranca A., Aragones J., Vara A., Redondo J.M., de Landazuri M.O. Pyrrolidine dithiocarbamate inhibits the production of interleukin-6 interleukin-8 and granulocyte-macrophage colony-stimulating factor by human endothelial cells in response to inflammatory mediators: modulation of NF-kappa B and AP-1 transcription factors activity. Blood 1996, 88:3482-3490.
    • (1996) Blood , vol.88 , pp. 3482-3490
    • Munoz, C.1    Pascual-Salcedo, D.2    Castellanos, M.C.3    Alfranca, A.4    Aragones, J.5    Vara, A.6    Redondo, J.M.7    de Landazuri, M.O.8
  • 24
    • 70449657727 scopus 로고    scopus 로고
    • EGF-induced ERK activation promotes CK2-mediated disassociation of alpha-Catenin from beta-Catenin and transactivation of beta-Catenin
    • Ji H., Wang J., Nika H., Hawke D., Keezer S., Ge Q., Fang B., Fang X., Fang D., Litchfield D.W., Aldape K., Lu Z. EGF-induced ERK activation promotes CK2-mediated disassociation of alpha-Catenin from beta-Catenin and transactivation of beta-Catenin. Mol. Cell. 2009, 36:547-559.
    • (2009) Mol. Cell. , vol.36 , pp. 547-559
    • Ji, H.1    Wang, J.2    Nika, H.3    Hawke, D.4    Keezer, S.5    Ge, Q.6    Fang, B.7    Fang, X.8    Fang, D.9    Litchfield, D.W.10    Aldape, K.11    Lu, Z.12
  • 25
    • 0037112514 scopus 로고    scopus 로고
    • Protein kinase CK2 promotes aberrant activation of nuclear factor-kappaB, transformed phenotype, and survival of breast cancer cells
    • Romieu-Mourez R., Landesman-Bollag E., Seldin D.C., Sonenshein G.E. Protein kinase CK2 promotes aberrant activation of nuclear factor-kappaB, transformed phenotype, and survival of breast cancer cells. Cancer Res. 2002, 62:6770-6778.
    • (2002) Cancer Res. , vol.62 , pp. 6770-6778
    • Romieu-Mourez, R.1    Landesman-Bollag, E.2    Seldin, D.C.3    Sonenshein, G.E.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.